Bristol Myers Squibb (BMY) Raw Materials (2010 - 2013)

Bristol Myers Squibb (BMY) has reported Raw Materials for 4 consecutive years, with $338.0 million the latest figure, recorded in Q1 2013.

• On a quarterly basis, Raw Materials rose 40.25% year-over-year to $338.0 million in Q1 2013; TTM through Mar 2013 was $338.0 million, a 40.25% increase from a year earlier, with the FY2012 full-year figure at $271.0 million, up 4.23% from the prior year.
• Raw Materials was $338.0 million for Q1 2013 at Bristol Myers Squibb, up from $271.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $357.0 million in Q2 2011 and troughed at $199.0 million in Q4 2010.
• A 4-year average of $264.8 million and a median of $261.5 million in 2011 frame the typical range for Raw Materials.
• The widest YoY moves for Raw Materials: up 44.39% in 2012, down 26.33% in 2012.
• Over 4 years, Raw Materials stood at $199.0 million in 2010, then surged by 30.65% to $260.0 million in 2011, then gained by 4.23% to $271.0 million in 2012, then rose by 24.72% to $338.0 million in 2013.
• The last three Raw Materials figures came in at $338.0 million (Q1 2013), $271.0 million (Q4 2012), and $296.0 million (Q3 2012), per Business Quant data.